| Literature DB >> 34833946 |
Didi Ma1,2,3,4, Lijun Wang2,3,4, Yibao Jin2,3,4, Lifei Gu2,3,4, Xiean Yu2,3,4, Xueqing Xie1,2,3,4, Guo Yin2,3,4, Jue Wang2,3,4, Kaishun Bi1, Yi Lu2,3,4, Tiejie Wang1,2,3,4.
Abstract
Rhodiola, especially Rhodiola crenulate and Rhodiola rosea, is an increasingly widely used traditional medicine or dietary supplement in Asian and western countries. Because of the phytochemical diversity and difference of therapeutic efficacy among Rhodiola species, it is crucial to accurately identify them. In this study, a simple and efficient method of the classification of Rhodiola crenulate, Rhodiola rosea, and their confusable species (Rhodiola serrata, Rhodiola yunnanensis, Rhodiola kirilowii and Rhodiola fastigiate) was established by UHPLC fingerprints combined with chemical pattern recognition analysis. The results showed that similarity analysis and principal component analysis (PCA) could not achieve accurate classification among the six Rhodiola species. Linear discriminant analysis (LDA) combined with stepwise feature selection exhibited effective discrimination. Seven characteristic peaks that are responsible for accurate classification were selected, and their distinguishing ability was successfully verified by partial least-squares discriminant analysis (PLS-DA) and orthogonal partial least-squares discriminant analysis (OPLS-DA), respectively. Finally, the components of these seven characteristic peaks were identified as 1-(2-Hydroxy-2-methylbutanoate) β-D-glucopyranose, 4-O-glucosyl-p-coumaric acid, salidroside, epigallocatechin, 1,2,3,4,6-pentagalloyglucose, epigallocatechin gallate, and (+)-isolarisiresinol-4'-O-β-D-glucopyranoside or (+)-isolarisiresinol-4-O-β-D-glucopyranoside, respectively. The results obtained in our study provided useful information for authenticity identification and classification of Rhodiola species.Entities:
Keywords: Rhodiola; UHPLC fingerprint; chemical pattern recognition; quality evaluation
Mesh:
Substances:
Year: 2021 PMID: 34833946 PMCID: PMC8618991 DOI: 10.3390/molecules26226855
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Typical UHPLC fingerprints of Rhodiola from six different species.
Figure 2Score plot of PCA on the first three principal components for Rhodiola samples.
Figure 3LDA score plot of training set samples (A); training set and testing set samples (B).
Figure 4PLS-DA/OPLS-DA score plot of training set samples (A,D); permutation test result (B,E); score plot of training set and testing set samples (C,F).
Identification of the characteristic peaks of Rhodiola by UHPLC-Q-TOF-MS/MS in negative ion mode.
| [M-H]- | ||||||
|---|---|---|---|---|---|---|
| Peak No. | Observed Mass (Da) | Error (ppm) | Formula | MS/MS | Identification | Type |
| 2 | 279.1091 | 0.9 | C11H20O8 | 117.0566[M-H-C6H10O5]−, | 1-(2-Hydroxy-2-methylbutanoate) β-D-glucopyranose | Acyclic acid glycoside |
| 4 | 325.0926 | −1 | C15H18O8 | 119.0500[M-H-Glu-CO2]−, 163.0399[M-H-Glu]− | 4-O-glucosyl-p-coumaric acid | Phenylpropanoid |
| 5 a | 299.1134 | −0.8 | C14H20O7 | 299.1155 [M-H]−, 179.0553 [Glu-H]−, 119.0498 [M-H-Glu-H2O]− | Salidroside | The phenethyl glycosides |
| 7 | 305.0665 | −0.3 | C15H14O7 | 221.0470[M-H-2C2H2O]−, 203.0331[M-H-2C2H2O-H2O]−, | Epigallocatechin | Flavonoids |
| 13 | 457.0773 | −1.0 | C22H18O11 | 305.0667[M-H-C7H5O4]−, 287.0568[M-H-C7H5O4-H2O]−, | Epigallocatechin gallate | Flavonoids |
| 36 a | 939.1112 | 0.3 | C41H32O26 | 939.1085[M-H]−, 769.0884[M-H-C7H6O5]−, 617.0785[M-H-C7H6O5-C7H4O4]−, 447.0578[M-H-2C7H6O5-C7H4O4]−, 169.0146[Galloy]− | 1,2,3,4,6-Pentagalloyglucose | Gallic acid derivative |
| 37 | 521.2028 | −0.1 | C26H34O11 | 491.1942[M-HCHO-H]−, 503.1883[M-H2O-H]−, | (+)-isolarisiresinol-4′-O-β-D-glucopy ranoside or (+)-isolarisiresinol-4-O-β-D-glucopyranoside) | Phenylpropanoid |
a Identification by reference substances.
The information of Rhodiola samples.
| Sample No. | Species | Origin | Specifications |
|---|---|---|---|
| 1–47/68–115 |
| Tibet | Processed drugs |
| 48–53/116–122 |
| Sichuan | Processed drugs |
| 54–57/123/124 |
| Xinjiang | Processed drugs |
| 58–61/125/126 |
| Jilin | Processed drugs |
| 62–65/127/128 |
| Qinghai | Processed drugs |
| 66 |
| Inner Mongolia | Processed drugs |
| 67 |
| Gansu | Processed drugs |
| 129 |
| Yunnan | Processed drugs |
| 130 |
| Guangxi | Processed drugs |
| 131 |
| Liaoning | Processed drugs |
| 132/141 |
| Tibet | Processed drugs |
| 133/142 |
| Hunan | Processed drugs |
| 134/143 |
| Sichuan | Crude drugs |
| 135–140/144–149 |
| / | Crude drugs |
| 150–153 |
| Tibet | Processed drugs |
| 154/155 |
| / | Crude drugs |
| 156/157 |
| / | Crude drugs |
| 158/159 |
| Tibet | Processed drugs |